Poland· PL-100515242
Wainzua
A eplontersen product containing eplontersen, registered in Poland by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Eplontersen
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05000456084918
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainWAINZUA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAAstrazeneca Ab
- United StatesWAINUAAstraZeneca Pharmaceuticals LP
- SwitzerlandWAINZUA, InjektionslösungAstraZeneca AG
- CanadaWAINUAASTRAZENECA CANADA INC
- United KingdomWainzua 45mg/0.8ml solution for injection pre-filled pensAstraZeneca UK Ltd
- NetherlandsWainzua 45 mg oplossing voor injectie in een voorgevulde penAstraZeneca AB
- FinlandWainzuaAstraZeneca AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/73534f3f-33b4-4117-a1dd-d68aa0a35fad GET /v1/drugs/73534f3f-33b4-4117-a1dd-d68aa0a35fad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "45 mg",
"packaging": "05000456084918 ¦ Rpz ¦ EU/1/24/1875/001 ¦ 161024\n1 wstrzykiwacz 0,8 ml",
"substance": "Eplontersenum 45 mg",
"common_name": "Eplontersen",
"pl_product_id": "100515242",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.